These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 33896271)
1. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma. Su X; Li H; Chen S; Qin C Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Dynactin mRNA Expression in Cutaneous Melanoma. Wang Q; Wang X; Liang Q; Wang S; Liao X; Li D; Pan F Med Sci Monit; 2018 Jun; 24():3752-3763. PubMed ID: 29864111 [TBL] [Abstract][Full Text] [Related]
3. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. Hao YP; Wang WY; Qiao Q; Li G Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884 [TBL] [Abstract][Full Text] [Related]
4. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related]
5. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
6. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. Qi C; Lei L; Hu J; Wang G; Liu J; Ou S J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801 [TBL] [Abstract][Full Text] [Related]
7. Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma. Wang S; Wang Q; Zhang X; Liao X; Wang G; Yu L; Zhang W; Zhou Q; Hu S; Yuan W Cancer Manag Res; 2018; 10():5807-5824. PubMed ID: 30510450 [TBL] [Abstract][Full Text] [Related]
8. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma. Li Y; Deng G; Qi Y; Zhang H; Jiang H; Geng R; Ye Z; Liu B; Chen Q Biomed Res Int; 2020; 2020():9716720. PubMed ID: 32695826 [TBL] [Abstract][Full Text] [Related]
10. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma. Ma W; Mei P World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196 [TBL] [Abstract][Full Text] [Related]
11. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma. Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB Front Immunol; 2020; 11():606164. PubMed ID: 33408717 [TBL] [Abstract][Full Text] [Related]
12. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas. Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009 [TBL] [Abstract][Full Text] [Related]
13. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma. Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420 [TBL] [Abstract][Full Text] [Related]
14. NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis. Ju Q; Li X; Zhang H; Yan S; Li Y; Zhao Y Oxid Med Cell Longev; 2020; 2020():3580719. PubMed ID: 33101586 [TBL] [Abstract][Full Text] [Related]
15. FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs). Zhang Z; Xiao Y; Zhao S; Liu J; Zeng J; Xiao F; Liao B; Shan X; Zhu H; Guo H J Transl Med; 2024 Sep; 22(1):833. PubMed ID: 39256832 [TBL] [Abstract][Full Text] [Related]
16. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas. Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312 [TBL] [Abstract][Full Text] [Related]
17. Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression. Ye T; Cheng Y; Li C Comput Math Methods Med; 2021; 2021():5086236. PubMed ID: 34367317 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma. Xu S; Tang L; Liu Z; Luo C; Cheng Q Front Immunol; 2021; 12():731048. PubMed ID: 34659218 [TBL] [Abstract][Full Text] [Related]
19. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma. Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186 [TBL] [Abstract][Full Text] [Related]
20. Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma. Zhang H; Zhang L; Tang Y; Wang C; Chen Y; Shu J; Zhang K Biomed Pharmacother; 2019 Oct; 118():109215. PubMed ID: 31545245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]